BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29897944)

  • 1. A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
    Adams O; Janser FA; Dislich B; Berezowska S; Humbert M; Seiler CA; Kroell D; Slotta-Huspenina J; Feith M; Ott K; Tschan MP; Langer R
    PLoS One; 2018; 13(6):e0197610. PubMed ID: 29897944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas.
    Adams O; Dislich B; Berezowska S; Schläfli AM; Seiler CA; Kröll D; Tschan MP; Langer R
    Oncotarget; 2016 Jun; 7(26):39241-39255. PubMed ID: 27250034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Her2-Targeted Therapy Induces Autophagy in Esophageal Adenocarcinoma Cells.
    Janser FA; Adams O; Bütler V; Schläfli AM; Dislich B; Seiler CA; Kröll D; Langer R; Tschan MP
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of LC3B and p62/SQSTM1 Expression in Gastric Adenocarcinoma.
    Kim JS; Bae GE; Kim KH; Lee SI; Chung C; Lee D; Lee TH; Kwon IS; Yeo MK
    Anticancer Res; 2019 Dec; 39(12):6711-6722. PubMed ID: 31810936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
    Chen S; Jiang YZ; Huang L; Zhou RJ; Yu KD; Liu Y; Shao ZM
    Clin Cancer Res; 2013 Dec; 19(24):6853-62. PubMed ID: 24141623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma.
    Langer R; Specht K; Becker K; Ewald P; Bekesch M; Sarbia M; Busch R; Feith M; Stein HJ; Siewert JR; Höfler H
    Clin Cancer Res; 2005 Oct; 11(20):7462-9. PubMed ID: 16243820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.
    Akashi E; Fujihara S; Morishita A; Tadokoro T; Chiyo T; Fujikawa K; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
    Oncol Rep; 2017 Jul; 38(1):506-514. PubMed ID: 28586026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.
    Niklaus M; Adams O; Berezowska S; Zlobec I; Graber F; Slotta-Huspenina J; Nitsche U; Rosenberg R; Tschan MP; Langer R
    Oncotarget; 2017 Aug; 8(33):54604-54615. PubMed ID: 28903368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of autophagy-related genes in esophageal adenocarcinoma.
    Zhu L; Dong L; Feng M; Yang F; Jiang W; Huang Z; Liu F; Wang L; Wang G; Li Q
    BMC Cancer; 2020 Oct; 20(1):943. PubMed ID: 32998713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
    Fichter CD; Timme S; Braun JA; Gudernatsch V; Schöpflin A; Bogatyreva L; Geddert H; Faller G; Klimstra D; Tang L; Hauschke D; Werner M; Lassmann S
    Int J Cancer; 2014 Oct; 135(7):1517-30. PubMed ID: 24510732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy.
    Plum PS; Löser H; Zander T; Essakly A; Bruns CJ; Hillmer AM; Alakus H; Schröder W; Büttner R; Gebauer F; Quaas A
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1031-1040. PubMed ID: 33300112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma.
    Hassan MS; Awasthi N; Li J; Schwarz MA; Schwarz RE; von Holzen U
    PLoS One; 2017; 12(2):e0171824. PubMed ID: 28225784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients.
    El Mashed S; O'Donovan TR; Kay E; O'Grady A; McManus D; Turkington RC; McKenna SL
    BMC Cancer; 2022 Aug; 22(1):908. PubMed ID: 35986318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma.
    Weh KM; Howell AB; Kresty LA
    Mol Carcinog; 2016 Nov; 55(11):1876-1885. PubMed ID: 27696537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.
    Mari L; Hoefnagel SJM; Zito D; van de Meent M; van Endert P; Calpe S; Sancho Serra MDC; Heemskerk MHM; van Laarhoven HWM; Hulshof MCCM; Gisbertz SS; Medema JP; van Berge Henegouwen MI; Meijer SL; Bergman JJGHM; Milano F; Krishnadath KK
    Gastroenterology; 2018 Sep; 155(3):784-798. PubMed ID: 29885883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
    Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC3B globular structures correlate with survival in esophageal adenocarcinoma.
    El-Mashed S; O'Donovan TR; Kay EW; Abdallah AR; Cathcart MC; O'Sullivan J; O'Grady A; Reynolds J; O'Reilly S; O'Sullivan GC; McKenna SL
    BMC Cancer; 2015 Aug; 15():582. PubMed ID: 26265176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma.
    Matuszcak C; Lindner K; Eichelmann AK; Hussey DJ; Haier J; Hummel R
    Surg Oncol; 2018 Sep; 27(3):392-401. PubMed ID: 30217293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.
    Xu T; Yuan Y; He C; Yang K
    Med Sci Monit; 2021 Jan; 27():e927850. PubMed ID: 33510126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.